METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS
- Application ID: EP17728484
- Status: █ Request for examination was made
This EP application has the IPC class G01 (MEASURING; TESTING). MorphoSys AG is specialized in G01. MorphoSys AG is specialised in G01 (MEASURING; TESTING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.
- 30.05.2016 - Priority Date (EP 20160171885)
- 07.12.2017 - Publication A1 (WO2017207574)
- 10.04.2019 - Publication A1 (EP3465214)